Taysha Gene Therapies
TSHA
#7675
Rank
โ‚ฌ0.25 B
Marketcap
1,26ย โ‚ฌ
Share price
-29.53%
Change (1 day)
-52.19%
Change (1 year)

Operating Margin for Taysha Gene Therapies (TSHA)

Operating Margin as of March 2025 (TTM): -1,071.61%

According to Taysha Gene Therapies's latest financial reports and stock price the company's current Operating Margin is -1,071.61%. At the end of 2024 the company had an Operating Margin of -1,070.39%.

Operating Margin history for Taysha Gene Therapies from 2023 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-1,070.39%55.19%
2023-689.72%-89.36%
2022-6,483.45%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.